Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic retinopathyA clinical update.

M Porta1, F Bandello

  • 1Department of Internal Medicine, University of Turin, Italy. massimo.porta@unito.it

Diabetologia
|December 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large choroidal cavern development in a patient with geographic atrophy.

Journal francais d'ophtalmologie·2024
Same author

Anomalous location of intracranial vessels in adults.

Radiologia·2022
Same author

Eruptive cherry angiomas and uveal melanoma: beyond a simple association.

Clinical and experimental dermatology·2021
Same author

Characterization of hand forces exerted during non-powered hospital bed pushing and pulling tasks.

International journal of occupational safety and ergonomics : JOSE·2020
Same author

Pyogenic granuloma after cosmetic eye whitening.

Archivos de la Sociedad Espanola de Oftalmologia·2020
Same author

Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort.

International journal of cancer·2018
Same journal

Unhealthy fat distribution as a sex-specific predictor of declining hippocampus insulin sensitivity.

Diabetologia·2026
Same journal

Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions.

Diabetologia·2026
Same journal

GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.

Diabetologia·2026
Same journal

Correction: Analysis of glycaemic control with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.

Diabetologia·2026
Same journal

History of infertility, risk of type 2 diabetes and HbA<sub>1c</sub> levels in the Nurses' Health Study II.

Diabetologia·2026
Same journal

Delayed maturation of the milk microbiome in women with type 1 diabetes.

Diabetologia·2026
See all related articles

Diabetic retinopathy, a leading cause of blindness, can be delayed by managing blood glucose and pressure. Early screening and new treatments offer hope for reducing diabetes-related vision loss.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Public Health

Background:

  • Diabetic retinopathy is the most common chronic complication of diabetes.
  • It is a leading cause of blindness, particularly in industrialized nations.
  • Despite advances, diabetes-related visual loss remains a significant public health concern.

Purpose of the Study:

  • To review the epidemiology and natural history of diabetic retinopathy.
  • To discuss current management strategies and their effectiveness.
  • To explore future directions in treatment and prevention.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of clinical trial outcomes for interventions.
  • Discussion of screening protocols and healthcare system challenges.

Related Experiment Videos

Main Results:

  • Near-normal blood glucose and blood pressure effectively delay retinopathy onset and progression.
  • Laser photocoagulation is effective for sight-threatening retinopathy.
  • Screening for sight-threatening retinopathy is highly cost-effective but underutilized.

Conclusions:

  • Diabetic retinopathy remains a major cause of preventable blindness.
  • Improved metabolic control, timely screening, and advanced therapies are crucial.
  • Ongoing research into pathogenesis-targeted treatments holds promise for the future.